Resultados de la búsqueda

Hamczyk MR*, Nevado RM, Gonzalo P, Andrés-Manzano MJ, Nogales P, Quesada V, Rosado A, Torroja C, Sánchez-Cabo F, Dopazo A, Bentzon JF, López-Otín C, Andrés V*. *co-corresponding authors. Endothelial-to-Mesenchymal Transition Contributes to Accelerated Atherosclerosis in Hutchinson-Gilford Progeria Syndrome. doi: 10.1161/CIRCULATIONAHA.123.065768 Circulation (2024) Aug 29 [Epub ahead of print]

Barettino A, González-Gómez C, Gonzalo P, Andrés-Manzano MJ, Guerrero CR, Espinosa FM, Carmona RM, Blanco Y, Dorado B, Torroja C, Sánchez-Cabo F, Quintas A, Benguría A, Dopazo A, García R, Benedicto I*, Andrés V*. *co-corresponding authors. Endothelial YAP/TAZ activation promotes atherosclerosis in a mouse model of Hutchinson-Gilford progeria syndrome. J Clin Invest (2024) Oct 1 [Epub ahead of print]

Benedicto I, Carmona RM, Barettino A, Espinós-Estévez C, Gonzalo P, Nevado RM, de la Fuente-Pérez M, Andrés-Manzano MJ, González-Gómez C, Rolas L, Dorado B, Nourshargh S, Hamczyk MR, Andrés V. Exacerbated atherosclerosis in progeria is prevented by progerin elimination in vascular smooth muscle cells but not endothelial cells. doi:10.1073/pnas.2400752121. Proc Natl Acad Sci U S A (2024) 121:e2400752121
Link to the full text in Repisalud

Palomo I, Wehinger S, Andrés V, García-García FJ, Fuentes E. RhoA/rho kinase pathway activation in age-associated endothelial cell dysfunction and thrombosis. J Cell Mol Med (2024) 28:e18153.
Link to the full text in Repisalud

Martinez-Campanario MC, Cortés M, Moreno-Lanceta A, Han L, Ninfali C, Domínguez V, Andrés-Manzano MJ, Farràs M, Esteve-Codina A, Enrich C, Díaz-Crespo FJ, Pintado B, Escolà-Gil JC, García de Frutos P, Andrés V, Melgar-Lesmes P, Postigo A. Atherosclerotic plaque development in mice is enhanced by myeloid ZEB1 downregulation. Nat Commun (2023) 14:8316
Link to the full text in Repisalud

Gonzalez-Granado JM, Del Monte-Monge A, Piqueras L, Andres V, Rius C. Analysis of Monocyte Recruitment During Inflammation by Intravital Imaging. Methods Cell Biol (2023) 2608:451-467

Díez-Díez M, Amorós-Pérez M, de la Barrera J, Vázquez E, Quintas A, Pascual-Figal DA, Dopazo A, Sánchez-Cabo F, Kleinman ME, Gordon LB, Fuster V, Andrés V*, Fuster JJ* *co-corresponding authors Clonal hematopoiesis is not prevalent in Hutchinson-Gilford progeria syndrome. doi: 10.1007/s11357-022-00607-2. Geroscience (2023) 45:1231-1236
Link to the full text in Repisalud

Andrés V, Díez J. Failing Hypertensive Heart: a Question of Altered Telomere Biology? Hypertension (2022) 79:2185-2187
Link to the full text in Repisalud

Macías Á, Díaz-Larrosa JJ, Blanco Y, Fanjul V, González-Gómez C, Gonzalo P, Andrés-Manzano MJ, da Rocha AM, Ponce-Balbuena D, Allan A, Filgueiras-Rama D, Jalife J, Andrés V Paclitaxel mitigates structural alterations and cardiac conduction system defects in a mouse model of Hutchinson-Gilford progeria syndrome Cardiovasc Res (2022) 118:503-516
Link to the full text in Repisalud

Matesanz N, Viana-Huete V, Zuriaga MA, Zorita V, Ferrer-Perez A, Amoros-Perez M, Carriero R, Kunderfranco P, Greco CM, Fuster JJ. TP53-MUTANT CLONAL HEMATOPOIESIS ACCELERATES EXPERIMENTAL ATHEROSCLEROSIS DEVELOPMENT Atherosclerosis (2022) 355